Empirical treatment of acute cystitis in women

International Journal of Antimicrobial Agents

Volumn 22, Issue 1, 2003, Pages 1-6

  Nicolle, Lindsay E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antibiotics; Cystitis; Empirical therapy; Guidelines

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; FLEROXACIN; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; GATIFLOXACIN; LEVOFLOXACIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIUM ISOLATE; CHONDROPATHY; CONGENITAL MALFORMATION; CYSTITIS; DRUG EFFICACY; DRUG SAFETY; EMPIRICISM; ESCHERICHIA COLI; FEMALE; HEMOLYTIC ANEMIA; HUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0038385267     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00101-8     Document Type: Review

References (43)

1. Hooton T.M., Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis. Clin. North Am. 11:1997;551-582.
2. Hopkin W.J., Heisey D.M., Lorentzen D.F., Uehling P.T. A comparative study of major histocompatability complex and red blood cell antigen phenotypes as risk factors for recurrent urinary tract infection in women. J. Infect. Dis. 177:1998;1296-1301.
3. Scholes P., Hooton T.M., Roberts P.L., Stapleton A.E., Gupta K., Stamm W.E. Risk factors for recurrent urinary tract infection in young women. J. Infect. Dis. 182:2000;1177-1182.
4. Foxman B., Frerichs R.R. Epidemiology of urinary tract infection: 1. Diaphragm use and sexual intercourse. Am. J. Public Health. 75:1985;1308-1313.
5. Fihn S.D., Boyko E.J., Normand E.A., et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am. J. Epidemiol. 144:1996;512-520.
6. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. The ECO-SENS Project. J. Antimicrob. Chemother. 51:2003;69-76.
7. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29:1999;745-758.
8. Wong E.S., McKevitt M., Running K., Counts G.W., Turck M., Stamm W.E. Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann. Int. Med. 102:1985;302-307.
9. Schaeffer A.J., Stuppy B.A. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J. Urol. 161:1999;207-211.
10. Gupta K., Hooton T.M., Roberts P.L., Stamm W.E. Patient initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann. Intern. Med. 135:2001;9-16.
11. Naber K.G. Treatment options for acute uncomplicated cystitis in adults. J. Antimicrob. Chemother. 46:(S1):2000;23-27.
12. Odenholt I., Bylander-Groth A., Frimon-Moller N., Rokstan K.S., Molstad S. Difference in antibiotic prescribing patterns between general practitioners in Scandinavia: A questionnaire study. Scand. J. Infect. Dis. 34:2002;602-609.
13. Strandberg K., Beermann B., Lonnerholm G. Treatment of urinary tract infections. 1990;Medical Products Agency.
14. Norwegian Board of Health. Antibiotics in general practice, 1999.
15. Ikaheimo R., Uhari M., Lumio J., et al. Clinical practice guidelines for the treatment of urinary tract infections. Duodecim. 116:2000;782-796.
16. Directorate of Public Health and the State Social Security Institute. http://lyf.landlaeknir.is .
17. Nicolle L.E. Pivmecillinam in the treatment of urinary tract infections. J. Antimicrob. Chemother. 46:(S1):2000;35-39.
18. Gupta K., Scholes D., Stamm W.E. Increasing prevalence of antimicrobial resistance causing acute uncomplicated cystitis in women. J. Am. Med. Assoc. 281:1999;736-738.
19. Mazzulli T., Skulnick M., Small G., et al. Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents. Can. J. Infect. Dis. 12:2001;289-292.
20. Nicolle L.E., Medsen K.S., DeBeeck G.O., et al. Three days pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand. J. Infect. Dis. 34:2002;487-492.
21. Nicolle L.E., Hoepelman A.I.M., Floor M.E., Verhoef J., Norgard K. Comparison of three days therapy with cefcanel daloxate or amoxicillin in the treatment of acute uncomplicated urinary tract infection. Scand. J. Infect. Dis. 25:1993;631-637.
22. McCarty J.M., Richard G., Huck W., et al. A randomized trial of short course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am. J. Med. 106:1999;292-299.
23. Raz R., Chazan B., Kennes Y., et al. Empiric use of trimethoprim-sulfamethoxazole in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP/SMX resistant organisms. Clin. Infect. Dis. 34:2002;1165-1169.
24. Nicolle L.E. Pivmecillinam for the treatment of acute uncomplicated urinary infection. Int. J. Clin. Pharmacol. 53:1999;612-617.
25. Christiaens T.C.M., DeMeyere M., Verschraegen G., Peersman W., Heytens S., De Macsencer J.M. Randomized controlled trial of nitrofurantoin in the treatment of uncomplicated urinary tract infection in adult women. Br. J. Gen. Pract. 52:2002;729-734.
26. WHO Global Strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001-2.
27. Gupta K., Schoses D., Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135:2001;41-50.
28. Davidson R., Davalcanti R., Brunton J.L., et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. New Engl. J. Med. 346:2002;747-750.
29. Iravani A., Klimberg I., Briefer C., Munera C., Kowalsky S.F., Echols R.M. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J. Antimicrob. Chemother. 43:(Suppl A):1999;67-75.
30. Henry D., Ellison W., Sullivan J., et al. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. Antimicrob. Agents Chemother. 42:1998;2262-2266.
31. Minassian M.A., Lewis D.A., Chattopadhyay D., Bovill B., Duckworth G.J., Williams J.D. A comparison between single-dose fosfomycin trometamol and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int. J. Antimicrob. Agents. 10:1998;39-47.
32. Stein G.E. Comparison of single-dose fosfomycin and 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin. Ther. 21:1999;1864-1872.
33. Richard G.A., Chavaramplakic P.M., Kirstein J.M., Orchard D., Yang J.Y. Single dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: Results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology. 59:2002;334-339.
34. Pitkajarvi T., Pyykonen M.-L., Kannisto K., Piipo T., Vitta P. Pivmecillinam treatment in acute cystitis. Three versus seven days study. Arzneim-Forsch/Drug Res. 40:1990;1156-1158.
35. Hooton T.M., Winter C., Tiu F., Stamm W.E. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. J. Am. Med. Assoc. 273:1995;41-45.
36. Nicolle LE. Screening for asymptomatic bacteriuria in pregnancy. The Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Canada Communication Group, Ottawa, 1994. p. 100-7.
37. Larsen H., Nielsen G.L., Moller M., Ebbesen F., Schonheyder H.C., Sorensen H.T. Birth outcome and risk of neonatal hypoglycaemia following in utero exposure to pivmecillinam: A population based cohort study with 414 exposed pregnancies. Scand. J. Infect. Dis. 33:2001;439-444.
38. Hernandez-Diaz S., Werler M.M., Walker A.M., Mitchell A.A. Folic acid antagonists during pregnancy and the risk of birth defects. New Engl. J. Med. 343:2000;1608-1614.
39. Schaefer C., Amoura-Elefant E., Vial T., et al. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur. J. Obstet. Gynecol. Reprod. Biol. 69:1996;83-89.
40. Weissenbacher E.R., Reisenberger K. Uncomplicated urinary tract infections in pregnant and non-pregnant women. Curr. Opin. Obstet. Gynecol. 5:1993;513-516.
41. Christensen B. Which antibiotics are appropriate for treating bacteriuria in pregnancy. J. Antimicrob. Chemother. 46:(Suppl 1):2000;29-34.
42. Krcmery S., Hromec J., Demesova D. Treatment of lower urinary tract infection in pregnancy. Int. J. Antimicrob. Agents. 17:2001;279-282.
43. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. New Engl. J. Med. 329:1993;1328-1334.